Orlistat for obesity.
D019440:Anti-Obesity Agents / Q000627:therapeutic use; D001067:Appetite Depressants / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003503:Cyclobutanes / Q000627:therapeutic use; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005252:Fees, Pharmaceutical; D006801:Humans; D007408:Intestinal Absorption; D007783:Lactones / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008049:Lipase / Q000037:antagonists & inhibitors; D009765:Obesity / Q000188:drug therapy*; D000077403:Orlistat; D010645:Phentermine / Q000627:therapeutic use
D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D004791:Enzyme Inhibitors; D007783:Lactones; D000077403:Orlistat; D010645:Phentermine; D008049:Lipase; C058254:sibutramine